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Aurantio-obtusin is a natural effective compound isolated from Semen Cassiae, which possesses hypo-
tensive and hypolipidemic effects. Although its hypotensive effect have been clariﬁed, mechanisms
Aurantio-obtusin relaxes systemic arteries remain unclear. This study was to investigate effects and
mechanisms of Aurantio-obtusin on isolated mesenteric arteries (MAs). We examined MAs relaxation
induced by Aurantio-obtusin on rat isolated MAs, expression and activity of endothelial nitric oxide
synthase (eNOS) and protein kinase B (AKT), and nitric oxide (NO) production in bovine artery endo-
thelial cells (BAECs). Findings showed Aurantio-obtusin elicited dose-dependent vasorelaxation with
phenylephrine (PE) precontracted rat MA rings (diameter: 200e300 mm), which can be diminished by
denudation of endothelium and inhibition of eNOS activity, while having no effect on rat isolated pul-
monary artery (PA) rings. Aurantio-obtusin increased NO production by promoting phosphorylations of
eNOS at Ser-1177 and Thr-495 in endothelial cells. Aurantio-obtusin also promoted phosphorylations of
Akt at Ser-473. PI3K inhibitor LY290042 could diminish vasorelaxation induced by Aurantio-obtusin.
Moreover Aurantio-obtusin also elicited dose-dependent vasorelaxation effect with PE precontracted
MA rings (diameter: 100e150 mm). Therefore, vasorelaxation induced by Aurantio-obtusin was depen-
dent on endothelium integrity and NO production, which mediated by endothelial PI3K/Akt/eNOS
pathway. Results suggest Aurantio-obtusin may offer therapeutic effects in hypertension, as a new po-
tential vasodilator.
© 2015 Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cardiovascular diseases remain the leading cause of death in the
under-developed country, with increasing rapidly in developing
countries. And incidence of death is 30% worldwide (1). The ap-
plications of most clinical medications were limited because pa-
tients have serious adverse reactions and high medical bills,Daqing, No. 1 Xinyang Street,
, PR China. Tel.: þ86 459 815
rmacological Society.
r B.V. on behalf of Japanese Pharmespecially after being given continuously for a prolonged period,
which limit their applications. Therefore, speciﬁc natural drugs
have been searched for the therapy of hypertension.
Aurantio-obtusin, 1, 3, 7-Trihydroxy-2, 8-diMethoxy-6-Methyl-
9, 10-anthracenedione (Fig. 1), the major bio-activity compound of
Semen Cassiae (2), has kinds of biological properties, such as anti-
oxidative, anti-coagulating and anti-hypertension. It has been re-
ported that Semen Cassiae could have signiﬁcant anti-hypertension
effect (3,4). However whether Aurantio-obtusin plays a pivotal role
in anti-hypertension effects of Semen Cassiae is still unclear. And
the underlying intracellular mechanisms of Aurantio-obtusin
induced anti-hypertension effect also should be further explored.
The development of cardiovascular disease has related with
vascular endothelium, which was conﬁrmed in previous researchacological Society. This is an open access article under the CC BY-NC-ND license
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release Nitric oxide (NO) by catalysis of arginine. It was already
reported NO was signiﬁcant for maintaining the balance of circu-
lation and modulating the vascular tone, as an important
endothelium-derived relaxation factor (6). Endothelial NO release
is mediated by phosphatidylinositol 3 kinase (PI3K) in coronary,
aortic, mesenteric, pulmonary, renal, and iliac arteries (7). PI3K and
protein kinase B (Akt) is activated by eNOS. Accumulating evidence
indicates that PI3K/Akt/eNOS pathway has the important role in
vascular constriction and remodeling (8,9). Vasoactive intestinal
polypeptide has vasorelaxation effect on rat isolated pulmonary
artery rings through PI3K/Akt/eNOS signaling pathway (10,11).
These data suggest that PI3K/Akt/eNOS signaling pathway plays a
vital role in regulating vascular activity.
Therefore, we hypothesize that Aurantio-obtusin relaxes the
systemic arteries by regulating the PI3K/Akt/eNOS signaling
pathway. Herein our results showed that Aurantio-obtusin relaxed
rat isolated mesenteric arteries (MAs), but not pulmonary arteries
(PAs), in a concentration-dependent manner. Moreover, vaso-
relaxation effect of rat MA rings induced by Aurantio-obtusin could
be diminished by removal of endothelium and using of eNOS in-
hibitor NG-nitro-i-arginine methyl ester (i-NAME) and PI3K in-
hibitor LY290042. Aurantio-obtusin increased the activity of eNOS
and Akt. Our study suggested that Aurantio-obtusin relaxed iso-
lated MAs through endothelial PI3K/Akt/eNOS signaling pathway.
2. Materials & methods
2.1. Ethics statement
Animal studies were conducted in conformity with the institu-
tional guide for the care and use of laboratory animals. Forty adult
male Wistar rats (200e250 g) used in this study were provided by
the Experimental Animal Center of Harbin Medical University. The
rats were housed at a controlled environment with 22 ± 2 C
constant temperature, 50 ± 10% relative humidity and the cycle of
light and night for 12 h. All rats were fed with standard rat chow
and water.
2.2. Drugs and chemicals reagents
Aurantio-obtusin (99% purity) was purchased from National
Institute for the control of Pharmaceutical and Biological Products
(NICPBP, Beijing, China). Phenylephrine, Nu-nitro-i-argining
methyl ester (i-NAME), LY290042 andWortamanninwere obtained
from Sigma Chemical Co (St Louis, MO). Cell-permeable ﬂuorescent
indicator 3-amino, 4-aminomethyl-2, 7-diﬂuroﬂuorescein diac-
etate (DAF-FMDA) was from Calbiochem (San Diego, CA, USA),
protein kinase B (Akt) antibody, phosphorylated Akt at Ser-473 (p-
Akt-Ser-473) antibody, phosphorylated endothelial NO synthase
(eNOS) at Ser-1177 (p-eNOS-Ser-1177) and Thr-495 (p-eNOS-Thr-
495) and total eNOS antibody were purchased from Cell SignalingFig. 1. The chemical structure of Aurantio-obtusin.Technology, Inc. (Danvers, MA, USA). All other reagents were from
common commercial sources.
2.3. PAs and MAs preparation
The experiments were carried out according to published pro-
tocols. Brieﬂy, rats were anesthetized with Chloral hydrate (6%,
0.5 ml/100 g). Dissected out lungs and mesenteries from thoracic
and abdominal cavities respectively, and immersed into cold
oxygenated Krebs solution (In mM: NaCl116, KCl4.2, CaCl22.5,
NaH2PO41.6, MgSO41.2, NaHCO322, and D-glucose11, PH7.4). Both
PAs and MAs were carefully dissected from lungs and mesenteries.
The rings (diameter: 200e300 mm) were cutted into 2 mme3 mm
length rings under the dissecting microscope and inserted with the
tungsten wires (diameter: 100 mm). And they were mounted in the
tension-detecting device (ALC-MPA, Shanghai Alcbio Biology
Technology Co, Ltd, China) and submerged in a water-jacketed or-
gan bath with 3 ml oxygenated Krebs solution. The second- or
third-order branches from the superior mesentery arteries (diam-
eter: 100e150 mm) were isolated and cutted into 1.5 mm length
rings. They were inserted on two stainless steel wires (diameter:
40 mm) and mounted in four-chamber wire myograph (model
620M, Danish Myo Technology, Gainesville, FL) with 3 ml oxygen-
ated Krebs solution. And they were sparged with 95% O2/5% CO2
andmaintained at 37Ccontinuously. The endothelium of rings was
removed by rubbing with the micro-tweezers. And the activity of
rings were conﬁrmed with acetylcholine (Ach 106 M) as described
previously (12).
2.4. Tension studies of PA and MA rings
Aurantio-obtusin was freshly dissolved in alcohol and stored at
4 C in dark. As previous described, both of PAs and MAs (diameter:
200e300 mm) were initially equilibrated with 0.3e0.4 g preload
respectively for 30e40 min before the studies started. And
MAs (diameter: 100e150 mm) were initially equilibrated with
0.05e0.1 g preload. The rings were incubated with phenylephrine
(106 M) in order to study the vasorelaxation induced by Aurantio-
obtusin. When the contraction of rings reached a steady state, they
were treated with Aurantio-obtusin (109 M to 105 M). To ensure
the volume of alcohol added had no effect on the precontracted
tone, Aurantio-obtusin solutionwas added into the tissue bath with
less than 0.1% volume. The cumulative concentration-response
curves were reported showing the ring tension at 5 min intervals.
On the other hand, the rings with no endotheliumwere also treated
with Aurantio-obtusin (109 M to 105 M). And the rings precon-
tracted were incubated with i-NAME (104 M) or LY290042
(3  105 M) respectively for 30 min then exposed to Aurantio-
obtusin again. All curves were recorded. At the end of studies, all
rings were treated with carbachol (106 M) in order to ensure the
rings vitality. Both the basal tension of 0.3 g and stable tension of
rings induced by phenylephrine (106 M) were regarded as 100%.
2.5. Cell culture
Primary cultured bovine artery endothelial cells (BAECs) were
prepared from neonatal bovine. In vitro experiment, the hearts of
neonatal bovine were offered by a local abattoir. The thoracic ar-
teries were separated and washed with HEPEs buffer (In mM:
NaCl145, KCl5.4, D-glucose10, HEPEs10, PH7.3) to remove blood.
The fat and excess adventitial were removed, and the endothelial
cells were scraped gently from thoracic arteries, then cultured ac-
cording to previous published manners (13,14). In this study, the
approval about use of neonatal bovinewas obtained from the Ethics
Committee of Laboratory Animals at Harbin Medical University.
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NO production in cultured BAECs was evaluated using DAF-
FMDA ﬂuorescence indicator by detecting endogenous NO. The
BAECs were grown on a micro cover glass of the 100 mm culture
dish to 80% conﬂuence. The cells were treated with Aurantio-
obtusin (105 M) alone, i-NAME (104 M) alone, Aurantio-obtusin
(105 M) plus i-NAME (104 M) immediately and respectively in
serum-free conditions. Then the cells were incubated with
5  106 M (ﬁnal concentration) DAF-FMDA (Calbiochem, San
Diego, CA, USA) for 1 h at 37 C and rinsed three times with
phosphate-buffered saline (PBS pH7.4). The cells were imaged us-
ing Nikon ﬂuorescent microscopy with 495-nm excitation and 515-
nm emission wavelengths.
2.7. Western blotting
BAECswere grown in serum-free DMEMmedium for 12 h before
they were treated with Aurantio-obtusin (105 M) alone, Wort-
mannin (107 M) alone, Aurantio-obtusin plus Wortmannin
(107 M), i-NAME (104 M) alone, Aurantio-obtusin (105 M) plus
i-NAME (104 M) for indicated time respectively. The proteins were
extracted from BAECs as previously reported (15). Equal amounts of
protein (20e50 mg) from each sample were subjected to electro-
phoresis on the 10% SDS-polyacrylamide gel and transferred onto
nitrocellulose membrane. After 2 h incubation in a blocking buffer
(Tris 20 mM, pH7.6, NaCl 150 mM, and Tween20 0.1%) containing
5% nonfat dry milk powder, the membranes were reacted with the
particular antibodies at suitable concentrations overnight 4 C,
followed by reaction with horseradish peroxidase-conjugated sec-
ondary antibodies and enhanced chemiluminescence reagents,
with b-actin as an internal control.
2.8. Statistical analysis
The composite data are expressed as means ± SEM. Statistical
analysis was performed with one-way ANOVA followed by Dun-
nett's test. Differences were considered to be signiﬁcant at P＜0.05.
3. Results
3.1. Vascular effect of Aurantio-obtusin on isolated rat PA and MA
rings
The MA (diameter: 100e150 mm) and PA rings preloaded with
0.4 g and 0.3 g respectively were equilibration for 30e40 min, and
then they were exposed to phenylephrine (106 M), which pro-
duced rapidly contraction of MA rings (0.7 ge1.0 g) and PA rings
(0.4e0.5 g). The peak contraction of MA rings were reached in
10 min and maintained for at least 20 min without evident decline.
During the vasorelaxation, administration of Aurantio-obtusin
(109105 M) produced concentration dependent relaxation of
MA rings (n ¼ 8, P＜0.01, Fig. 2A and C). At the maximum effect,
Aurantio-obtusin (105 M) relaxed the MAs by 32.85 ± 1.32%. Next
we explored whether similar results would be obtained with rat PA
rings. Results showed that Aurantio-obtusin had no effects on rat
precontracted PA rings (n ¼ 8, Fig. 2B and C). These data suggested
that concentration-dependent vasorelaxation induced by Aurantio-
obtusin was speciﬁcally on rat MAs, but not on rat PAs.
3.2. Role of endothelium and i-Name in MAs vasorelaxation
induced by Aurantio-obtusin
To investigate the role of endothelium in the vasorelaxation
induced by Aurantio-obtusin, we pretreated MA rings with orwithout endothelium respectively with phenylephrine (106 M),
then added Aurantio-obtusin (105 M), the relaxation induced by
Aurantio-obtusin in MA rings without endothelium were dimin-
ished markedly compared with the endothelium intact control
(n ¼ 12, Fig. 3A). Aurantio-obtusin (105 M) reduced the vascular
tension to 8.97 ± 2.38% in the endothelium denuded MA rings
(n ¼ 12, Fig. 3C).
NO is a major vasorelaxant in endothelium and the effect of NO
was studied with NG-nitro-i-arginine methyl ester (i-NAME, eNOS
inhibitor). To test whether endothelium NO involved in the MAs
relaxation induced by Aurantio-obtusin, MA rings were pretreated
with i-NAME (104 M) for 30 min before precontracted with
phenylephrine (106 M). The MAs vasorelaxation of Aurantio-
obtusin was signiﬁcantly diminished (n ¼ 12, Fig. 3B). Aurantio-
obtusin (105 M) reduced the vascular tension to 10.93 ± 1.61% in
the presence of i-NAME, which is 67% less as compared to that
without i-NAME (n ¼ 12, Fig. 3D).
3.3. The increase of NO production induced by Aurantio-obtusin
To determine whether NO release indeed is regulated by
Aurantio-obtusin (105 M), the intracellular NO production in
cultured BAECs were measured using DAF-FM DA ﬂuorescence in-
dicator. Aurantio-obtusin increased NO production in BAECs,
meanwhile the eNOS inhibitor i-NAME (104 M) diminished this
effect (Fig. 4A). The relative intensity of DAF-FM DA ﬂuorescence
suggested that Aurantio-obtusin stimulated NO production rapidly
in BAECs (n ¼ cell number, P＜0.01, Fig. 4B).
3.4. The activity of eNOS enhanced by Aurantio-obtusin in cultured
BAECs
Which mechanisms underlie the NO production by Aurantio-
obtusin, and which intra-endothelial signaling systems play a
role? To address these questions, we studied the expression and
activity of eNOS in cultured BAECs.
It is known that the protein phosphorylation at residue Ser-1177
increases eNOS activation, while phosphorylation at Thy-495 re-
sults in eNOS inhibition (16). Therefore, we examined phosphory-
lation levels at the two sites using phosphorylation-speciﬁc
antibodies. The BAECs were treated with Aurantio-obtusin
(105 M). We found the density band of Ser-1177 treated by
Aurantio-obtusinwas stronger than that of control. On the contrary,
the density band of Thr-495 treated with Aurantio-obtusin was
decreased as compared with control group. The eNOS inhibitor i-
NAME (104 M) signiﬁcantly diminished the level of eNOS phos-
phorylation at Ser-1177 and increased the level of eNOS phos-
phorylation at Thy-495 as compared with BAECs treated by
Aurantio-obtusin. The expression of total eNOS had no change
(n ¼ 3, Fig. 5). These results indicated that Aurantio-obtusin tran-
siently enhanced the activity of eNOS by increasing the level of
eNOS phosphorylation at Ser-1177 and decreasing the level of eNOS
phosphorylation at Thy-495.
3.5. Relaxation induced by Aurantio-obtusin through the PI3K/Akt
signaling pathway
Subsequently, we examined the role of PI3K/Akt signaling
pathway in vasorelaxation induced by Aurantio-obtusin. MAs were
pretreated with the PI3K/Akt inhibitor LY290042 (3  105 M).
Then, added Aurantio-obtusin (105 M) after a precontraction with
phenylephrine (106 M). Relaxation induced by Aurantio-obtusin
was diminished markedly after a treatment with LY290042
(3  105 M) (n ¼ 12, 5.16 ± 0.65%), which was signiﬁcantly lower
than the control rings (n ¼ 12, P＜0.01, Fig. 6).
Fig. 2. Effect of Aurantio-obtusin on rats MA and PA rings precontracted with 106 M phenylephrine. (A) Cumulative dosing of Aurantio-obtusin had dilatation effect on pre-
contracted rat MA rings at concentration 105 M. (B) Cumulative dosing of Aurantio-obtusin had no effect on precontracted rat PA rings at concentration 105 M. (C) Concentration-
response curves of Aurantio-obtusin in rats MA and PA rings. Results are expressed as mean ± S.E.M. (n ¼ 8) **P＜0.01 versus control group, “AO” means Aurantio-obtusin, “PE”
means phenylephrine, “CARB” means carbachol.
Fig. 3. Effect of endothelium and NO in Aurantio-obtusin induced Rats MAs relaxation. (A) Endothelium denudation diminished the vasorelaxation elicited by cumulative dosing of
Aurantio-obtusin. (C) Concentration-response curves of endothelium intact and denuded of Aurantio-obtusin on rats MA rings. (B) Inhibition of eNOS by i-NAME (104 M) on
endothelium intact MA rings signiﬁcantly diminished vasorelaxation effect induced by cumulative dosing of Aurantio-obtusin. (D) Concentration-response curves of i-NAME on
endothelium intact MA rings. Results are expressed as mean ± S.E.M. (n ¼ 8) **P＜0.01 versus control group, “AO” means Aurantio-obtusin, “PE” means phenylephrine, “CARB”
means Carbachol, “EI” means endothelium intact, “ED” means endothelium denuded.
Fig. 4. Effects of Aurantio-obtusin on NO production in BAECs. Basal NO production is visualized with DAF-FM. BAECs were treated with Aurantio-obtusin. Evident increase of DAF-
FM ﬂuorescent intensity was seen. (Ab) Aurantio-obtusin stimulated the release of NO production. (Ad) The eNOS inhibitor i-NAME (104 M) diminished this effect. (B) Densi-
tometric analysis of DAF-FM assays. Results are expressed as mean ± S.E.M. (n ¼ 3) **P＜0.01 compared with others groups. “NC” means negative control, “AO” means Aurantio-
obtusin, “i-N” means eNOS inhibitor i-NAME.
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Fig. 5. Effect of Aurantio-obtusin on the phosphorylation and protein of eNOS in BAECs. (A) Aurantio-obtusin up-regulated the level of phosphor-eNOS at Ser-1177 and down-regulated
the level of phosphor-eNOS at Thr-495. But Aurantio-obtusin had almost no effect on the expression of total eNOS. The eNOS inhibitor i-NAME (104 M) blocked the eNOS phos-
phorylation at Ser-1177 and Thy-495 stimulated by Aurantio-obtusin, thus inhibited the activity of eNOS. (B, C, and D) Densitometric analysis of the Western blot assays. Results are
expressed as mean ± S.E.M. (n ¼ 3) **P＜ 0.01 compared with others groups. “NC” means negative control, “AO” means Aurantio-obtusin, “i-N” means eNOS inhibitor i-NAME.
Fig. 6. Effect of PI3K/Akt in Aurantio-obtusin induced Rats MAs relaxation. (A) LY290042 (3  105 M) (PI3K inhibitor) signiﬁcantly diminished vasorelaxation effect induced by
cumulative dosing of Aurantio-obtusin. (B) Concentration-response curves of LY290042 (3  105 M) on endothelium intact MA rings. Results are expressed as mean ± S.E.M.
(n ¼ 12) **P＜0.01 versus control group, “AO” means Aurantio-obtusin, “PE” means phenylephrine, “CARB” means carbachol, “EI” means endothelium intact.
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induced eNOS activation
The eNOS is known to bind with Akt after the Akt is phos-
phorylated at Ser-473, leading to Akt activation (17). To explore
whether Aurantio-obtusin affects on PI3K/Akt signaling pathway,
the activity and expression of Akt were examined in BAECs treated
with Aurantio-obtusin. Similar to eNOS phosphorylation at Ser-
1177, Aurantio-obtusin enhanced the Akt phosphorylation at Ser-
473, not affected the expression of total Akt (n ¼ 3, P＜0.01,
Fig. 7). The results suggested that Aurantio-obtusin also transiently
enhanced the activity of Akt.
To further conﬁrm whether PI3K/Akt signaling pathway par-
ticipates in Aurantio-obtusin-induced increase of eNOS phosphor-
ylation at Ser-1177 and NO production, we blocked PI3K/Akt
signaling pathway with Wortmannin (107 M). Wortmannin
(107 M) signiﬁcantly attenuated Aurantio-obtusin induced Aktphosphorylation at Ser-473 in BAECs (n ¼ 3, P＜0.01, Fig. 7). All of
these results indicated that activation of PI3K/Akt signaling
pathway was necessary for eNOS activity and NO production
induced by Aurantio-obtusin.
3.7. Vascular effect of Aurantio-obtusin on isolated rat MA
(diameter: 100e150 mm) rings
Blood pressure levels are determined by vascular resistance. To
examine the effect of Aurantio-obtusin on vascular reactivity of
small resistance blood vessels, we isolated the second- or third-
order branches from the superior mesentery arteries (diameter:
100e150 mm) and prepared the vascular rings. The rings (diameter:
100e150 mm) preloaded with 0.05e0.1 g were equilibration for
30e40 min, and then they were exposed to phenylephrine
(106 M). The peak contraction of rings (diameter: 100e150 mm)
were reached in 10 min and maintained for at least 20 minwithout
Fig. 7. Effect of Aurantio-obtusin on the phosphorylation and protein of Akt in BAECs. (A) Aurantio-obtusin up-regulated the level of phosphor-Akt at Ser-473. But Aurantio-obtusin
had almost no effect on the expression of total Akt. The PI3K inhibitor Wortmannin (107 M) diminished the level of Akt phosphorylation at Ser-473 stimulated by Aurantio-obtusin,
thus inhibited the activity of Akt. (B and C) Densitometric analysis of the Western blot assays. Results are expressed as mean ± S.E.M. (n ¼ 3) **P＜0.01 compared with others groups.
“NC” means negative control, “AO” means Aurantio-obtusin, “Wm” means PI3K/Akt inhibitor Wortmannin.
Fig. 8. Effect of Aurantio-obtusin on rats MA rings (diameter: 100e150 mm) precontracted with 106 M phenylephrine. (A) Cumulative dosing of Aurantio-obtusin had dilatation
effect on precontracted rat MA rings at concentration 105 M. (B) Concentration-response curves of Aurantio-obtusin in rats MA rings (diameter: 100e150 mm). Results are
expressed as mean ± S.E.M. (n ¼ 7) *P < 0.005 versus control group, “AO” means Aurantio-obtusin, “PE” means phenylephrine.
S. Li et al. / Journal of Pharmacological Sciences 128 (2015) 108e115 113evident decline. During the vasorelaxation, administration of
Aurantio-obtusin (109105 M) produced concentration depen-
dent relaxation of rings (diameter: 100e150 mm) (n ¼ 7, P＜0.05,
Fig. 8). At the maximum effect, Aurantio-obtusin (105 M) relaxed
the MAs by 92.14 ± 0.03%. These data suggested that Aurantio-
obtusin induced the relaxation of rat MA small resistance blood
vessels on concentration-dependent way. Moreover, the relaxation
range was bigger than MA rings (diameter: 200e300 mm).
4. Discussion
This is the ﬁrst systematic study of cellular mechanisms for
vasorelaxation by Aurantio-obtusin.
Aurantio-obtusin relaxed precontracted rat MAs (200e300 and
100e150 mm respectively) in a concentration-dependent manner
(106 M to 105 M), whereas there is no effect on rat PAs in our
study. Moreover, the vascular relaxation effect of Aurantio-obtusin
on rat MAs depended on the functional integrity of the endothe-
lium and NO production. Our results indicated that Aurantio-
obtusin acted on the PI3K/AKT signaling pathway to enhanceeNOS activity. Aurantio-obtusin (105 M) activated Akt through
phosphorylation at Ser-473 in BAECs, enhanced eNOS activation
via phosphorylation at Ser-1177 and Thr-495, and stimulated
endothelial NO production, leading to MAs relaxation in 5 min.
The PI3K inhibitor LY290042 (3  105 M) and Wortmanin
(107 M) diminished these effects. These results suggested
Aurantio-obtusin relaxed systemic arteries through endothelial
PI3K/AKT/eNOS/NO signaling pathway, as a potent systemic ar-
teries vasodilator.
Semen Cassiae is a well known traditional Chinese medicine
that has been used to treat hypertension patient for hundreds of
years. Aurantio-obtusin, an active and main content of Semen
Cassiae, has been reported that it has the anti-hypertensive role
derived from natural products. It also plays an important role in
anti-oxidative, anti-dementia, anti-coagulating activity and cyto-
toxicity in tumor (18). However, limited information of Aurantio-
obtusin is available in the effect on MAs and underlying mecha-
nism, which is vital in the therapy of hypertension. The present
study is the ﬁrst to demonstrate that Aurantio-obtusin (105 M)
relaxed isolated rat mesenteric arteries.
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endogenous vasodilative agents, such as NO, COX-derived products,
and endothelium-derived hyperpolarization factors (EDHFs) which
regulate vascular tone (19e21). NO is the major vasodilator in the
endothelium-dependent vasorelaxation. The production of endo-
thelial NO is tightly regulated by the level of its synthesis through
the oxidation of i-arginine by NO synthases (eNOS) in pulmonary
circulation (22).
Which underlying mechanism of Aurantio-obtusin mediated rat
MAs relaxation? We found that denudation of endothelium and
inhibition of NO production with i-NAME (104 M) diminished the
vasodilatation effect from Aurantio-obtusin, suggesting that vaso-
dilatation effect from Aurantio-obtusin relies on endothelium
integrity and NO generation. And the effect was most possible from
eNOS activation.
Phosphorylations at Ser-617, Ser-635, Ser-1177 and Ser-1179 are
important for eNOS activation, whereas phosphorylations at Ser-
116, Thr-495 and Thr-497 cause inhibition of eNOS activity (23).
Our study showed that Aurantio-obtusin increased the level of
phosphor-eNOS (Ser-1177) and inhibited the level of phosphor-
eNOS (Thr-495), which means that Aurantio-obtusin activated
eNOS by phosphorylation of Ser-1177 and phosphorylation of Thr-
495. These observations indicated that Aurantio-obtusin stimu-
lated NO production by eNOS in BAECs.
It was reported that eNOS is regulated by endothelial PI3K/AKT
signaling pathway (24). Akt kinase (protein kinase B) is the serine/
threonine kinase activated by several phosphatidylinositol-
dependent protein kinases. Phosphorylation of Ser-473 on Akt is
coincident with Akt activation in vivo and vitro, which has been
used as a marker for Akt activity (25,26). Activated Akt increased
expression or activity of eNOS and NO production in endothelial
cells by directly phosphorylation eNOS at Ser-1177 and Thr-495. Our
results indicated that Aurantio-obtusin also played a role in the
PI3K/AKT signaling pathway to elevate eNOS activity for several
reasons: (1) Akt phosphorylation at Ser-473 was stimulated by
Aurantio-obtusin and blocked by the PI3K inhibitor. (2) Enhanced
eNOS phosphorylation at Ser-1177 was almost completely elimi-
nated in the presence of PI3K/AKT inhibitor. (3) Akt phosphorylation
at Ser-473 was consistent with eNOS phosphorylation at Ser-1177.
Therefore, the activation of PI3K/AKT signaling pathway is crucial
in the endothelial NO release system induced by Aurantio-obtusin.
We found that Aurantio-obtusin had modest vasorelaxation
effect on rat MAs (systemic arterial system), but no effect on rat PAs
(pulmonary arterial system). The reason may be related to different
vascular structures and vasoactive mediators. It's potential appli-
cation for regulating differentiated tone of systemic circulation and
pulmonary circulation.
In a word, Aurantio-obtusin, the natural product, contributed to
a state of vasorelaxation on Rat MAs, but not PAs. Moreover, for the
ﬁrst timewe found the vasorelaxation induced by Aurantio-obtusin
on MAs was speciﬁc and NO dependent. The vasorelaxation
induced by Aurantio-obtusin is mediated through endothelial
intracellular PI3K/Akt/eNOS/NO signaling pathway in BAECs. This
study provides a new potential vasodilator for the therapy of
arterial hypertension.
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